Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
According to the Wall Street Journal, insider sources said a major update to Microsoft’s AI chatbot could be released before the end of the month, designed to be more reliable at answering medical queries.
The Accountability Board has submitted an official proposal for UnitedHealth Group to separate its CEO and board chair positions, both currently held by Stephen Hemsley.
Qualtrics, which uses artificial intelligence to measure public satisfaction and consumer trends, is buying Press Ganey outright, citing the need for more healthcare-specific data to improve its technology.
The new contract was signed just ahead of the Oct. 20 deadline. The insurer and academic health system were in dispute over reimbursement rates. The exact terms of the new multi-year agreement are unknown.
The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear.
For whatever reason, the grownups seem to get all the attention when talk turns to AI in healthcare. All the kiddos get to do is look on and listen in. Now comes a worthy little effort to balance the seesaw.
The U.S. Food and Drug Administration has its hands full making sure medical AI products are safe, efficacious and trustworthy before they hit the market. The rise of ever-more-innovative iterations of the technology—not least generative AI—is only adding to the burden.